Euda Health amends note conversion terms with investor for $162,500 balance By Investing.com
Key Takeaways
- Euda Health amended the conversion terms of a $1,000,000 convertible promissory note with an institutional investor.
- The remaining $162,500 balance of the note will not be converted until after October 31, 2025.
- After October 31, the investor can convert the balance into 81,250 shares or request cash repayment by November 17, 2025.
- To date, $837,500 of the original note has already been converted into ordinary shares.
- Euda Health stated it does not intend to issue additional put requests for further note sales under the existing purchase agreement.
Euda Health announced an amendment, detailed in an SEC filing, to the terms of a $1,000,000 convertible promissory note issued to an institutional investor on August 1, 2025. To date, $837,500 of the principal has been converted into ordinary shares. The recent amendment, dated October 2, 2025, modifies a previous agreement that set a conversion trigger based on the stock price. Under the new terms, the investor agrees not to convert the remaining $162,500 until after October 31, 2025. Following this date, the investor can choose to convert the balance into 81,250 ordinary shares at $2.00 each or demand cash repayment of $162,500 by November 17, 2025. Furthermore, Euda Health confirmed it does not plan to issue additional put requests for further note sales under the current purchase agreement.
